Partnerships

Developing novel products based on PRINT™ technology is at the core of Liquidia's business strategy. Liquidia is currently developing products in the Life Sciences and Materials Science sectors through both internal development projects and collaborations with external organizations. These collaborations enable the development of important, novel products that will ultimately provide significant benefits to our partners, patients, and consumers.

Collaborations

Liquidia has already initiated a number of strategic partnerships to leverage the PRINT™ platform for the advancement of valuable new products.

In Life Sciences, collaborations will likely include projects aimed at overcoming solubility challenges, enabling optimized inhaled therapeutics, and Engineered Drug Therapies™ such as targeted, intracellular delivery of biologics or small molecules.

Opportunities for collaboration in Materials Science include rapid prototyping and joint development agreements, as well as licensing and manufacturing relationships. Liquidia welcomes the opportunity to explore strategic partnerships in Materials Science that are focused on commercial applications for PRINT™ technologies and intellectual property.

The flexibility of the PRINT™ product platform enables Liquidia to pursue partnerships with a range of companies. Examples of previous prototyping projects include:

	Particles and arrays for Fortune 100 Defense Company
	Active Layer Manufacturing for Publicly Traded Display Company
	Optical films for Global 500 display company
	Specialized coatings for Fortune 100 Technology Company
	Gene chip design for Private Genomics Firm
	Specialized Coatings for Private Microfluidics Firm
	Advanced chemicals/materials for Fortune 500 Chemicals Company
	Fuel cell membranes for Fortune 10 Auto Manufacturer

For specific inquiries please contact info@liquidia.com.